Tokyo, Japan and Cambridge, UK, 29 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Neurocrine Biosciences, Inc. announced that it had presented new positive data from ...
The Royalty Pharma PLC-Bond has a maturity date of 9/2/2025 and offers a coupon of 1.2000%. The payment of the coupon will take place 2,0 times per biannual on the 02 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback